Publications
By Year
Now showing items 181-200 of 5702 records
Redefining Osteoporosis: A Global Call for Equity, Evidence, and Access- Perspectives from Asia and Africa.
Lakshmi Nagendra; Khushboo Agarwal; Nitin Kapoor; Saptarshi Bhattacharya; Khayati Moudgil; A B M Kamrul-Hasan; Syed Abbas Raza; Varsha Bangalee; Sourabh Sharma; Mohammad Wali Naseri; Payal Buckoreelall Chintaram; Dayakshi D K Abeyaratne; Shahjada Selim; Hidayat Kassim; G P Dhakal; Dina Shrestha; Moosa Murad; Hinde Iraqi; Hedson Alves Martins; Charlotte Bavuma Munganyinka; Abodo Jacko; Sedrik Ahomagnon; Ankia Coetzee; Sanjay Kalra
ENDOCRINE PRACTICE : OFFICIAL JOURNAL OF THE AMERICAN COLLEGE OF ENDOCRINOLOGY AND THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS - 30 Jan 2026
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational study.
Abdul Waheed Khan; Misbah Aziz; Karly C Sourris; Jairo P Cortes; Tomasz J Block; Aozhi Dai; Scott Maxwell; Jun Okabe; Emma Pyper; Francesco Paneni; Mark E Cooper; Karin Am Jandeleit-Dahm
CARDIOVASCULAR DIABETOLOGY - 29 Jan 2026
Endothelial to mesenchymal transition (EndMT), the transformation of endothelial cells into a mesenchymal-like state, is regulated by various factors, including transcription factors such as activator protein 1 (AP-1). While recent studies have confirmed the role of EndMT in atherosclerosis, the involvement of AP-1 in EndMT, particularly in the context of human diabetes, remains unclear. This s...
Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas.
Felix Teufel; Katherine Orgutsova; Irini Genitsaridi; Rodrigo M Carrillo-Larco; Jithin Sam Varghese; Maja E Marcus; Julian W Sacre; Seyedeh Forough Sajjadi; Faraja Chiwanga; Jennifer Manne-Goehler; Jacqueline Seiglie; David Flood; Jessica Harding; Paraskevi Salpea; Agus Salim; Edward J Boyko; Dianna J Magliano; Mohammed K Ali
DIABETES CARE - 28 Jan 2026
Undiagnosed diabetes leads to delayed treatment and increased risk of complications, exacerbating global disease burdens. In this study, we estimated the prevalence and absolute numbers of individuals with undiagnosed diabetes globally and across regions and quantified gaps in national diabetes detection efforts. We systematically compiled estimates of biomarker-based diabetes prevalence and se...
Statin initiation among cancer survivors with asymptomatic coronary atherosclerosis.
Cheng Hwee Soh; Shristy Shrestha; Kristyn Whitmore; Batsheva Greenbaum; Atro Azad; Melinda J Carrington; Joel Smith; Thomas H Marwick
CARDIO-ONCOLOGY (LONDON, ENGLAND) - 19 Jan 2026
Multi-omic analysis of human PHACTR1 signaling networks.
Kathryn Wolhuter; Lijiang Ma; Nicole S Bryce; Osvaldo Contreras; Natalie Mellett; Ling Zhong; Chris Thekkedam; Siiri E Iismaa; Corey Giles; Richard P Harvey; Thomas Hennessy; Chris Fouracre; David Bradley; Peter J Meikle; Johan L M Björkegren; Jason C Kovacic
COMMUNICATIONS BIOLOGY - 19 Jan 2026
Genetic studies have linked PHACTR1 to a range of vascular diseases, underscoring its pivotal role in vascular biology. However, the full spectrum of PHACTR1-mediated signaling pathways remains largely unexplored. To bridge this gap, we employ a multi-omics pipeline combining pairwise differential expression analysis, multi-omics pathway integration, and feature-level correlation analyses acros...
A Context-Adapted Diabetes Prevention Program (Small Steps for Big Changes) in Australia: Protocol for a Hybrid Implementation-Effectiveness Study.
Genevieve N Healy; Sjaan R Gomersall; David W Dunstan; Elisabeth A H Winkler; Katherine A Heseltine; Grace Q Sim; Fiona Mason; Denis Giguere; Michael Tsiamis; Mary E Jung; Ana D Goode
19 Jan 2026
With type 2 diabetes rates escalating worldwide, including in Australia, effective, acceptable, sustainable, and scalable diabetes prevention programs are needed. Small Steps for Big Changes (SSBC) is a Canadian-developed, community-delivered diet and exercise counseling intervention for individuals at risk of type 2 diabetes. The 3- to 6-week intervention can be delivered by trained non-health...
Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.
Jennifer Ngan; Yee Wen Kong; Hanna C Jones; Jenna Goad; Adamandia Kriketos; Adele Manzoney; Alicia J Jenkins; Christopher J Nolan; Delaney Randle; Frank Gao; Joanne Fenn; Mahesh M Umapathysivam; Melinda Felder; Michael Lh Huang; Miyuki Nakano; Pamela Taylor; Ria Haryung Lee; Richard J MacIsaac; Sara Vogrin; Spiros Fourlanos; Stephen Stranks; Elif I Ekinci; David N O'Neal
DIABETES TECHNOLOGY & THERAPEUTICS - 12 Feb 2026
We aimed to assess continuous ketone monitor (CKM) profiles in community-dwelling adults with type 1 diabetes. Two-weeks CKM (Abbott, Alameda, CA) run-in data (PARTNER study: ACTRN12624000448549) were analyzed by groups <0.6, 0.6-0.9, and ≥1.0 mmol/L defined as at least one reading in the highest ketone range. Results are median interquartile range (IQR). Sixty-four participants (age 49.8 [40.2...
Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled Trial.
Tom Wilkinson; Natalie Nanayakkara; David Burren; Alicia Jenkins; Jonathan Williman; Celeste Keesing; Erin Boyle; Yasser Elghattis; Alison Bennett; Tim Gunn; Martin de Bock; Neale D Cohen
DIABETES TECHNOLOGY & THERAPEUTICS - 12 Feb 2026
Current automated insulin delivery (AID) systems recommend manual insulin delivery prior to meals (hybrid closed-loop [HCL]). Data are needed on the efficacy of an AID system without meal announcement. In this randomized, open-label, parallel-arm trial, we established participants with type 1 diabetes aged 18-70 years on an open-source AID system, with meal announcement, during a 12-week run-in...
Structural and functional modifications of neuronal lipid rafts: implications for HIV-associated neurological disorders.
Ying Fu; Kevin Huynh; Nigora Mukhamedova; Ben Crossett; Denise Tran; Siera Martinez; Anelia Horvath; Hong-Yin Wang; Ivan Castello-Serrano; Rosanna Ippolitto; Farhad Parhami; Peter J Meikle; Ilya Levental; Michael Bukrinsky; Dmitri Sviridov
JOURNAL OF NEUROINFLAMMATION - 11 Feb 2026
The association between smoking and diabetic neuropathy: a systematic review and meta-analysis.
Sana Bader; Sanah Hasan; Dianna J Magliano; Rakibul M Islam; Shanika Palawaththa; Lorena Romero; Md Nazmul Karim
24 Dec 2025
The study aimed to systematically review the evidence on the association between smoking and the risk of diabetic neuropathy, with a particular emphasis on the risk of peripheral neuropathy among individuals with diabetes mellitus. MEDLINE, EMBASE, SCOPUS, and CENTRAL databases were searched for studies published before August 2024. Cross-sectional, case-control, and cohort studies that assesse...
Perimenopausal Hormone Replacement Treatments as a Geroprotective Approach - Adapting Clinical Guidance.
Jaron Rabinovici; Henk-Peter Oonk; Zhongwei Huang; Tashiya Mirando; Moran Zhou; Tzipora Strauss; Lia-Raluca Olari; Dominika Wilczok; Andrea B Maier; Evelyne Bischof
AGING AND DISEASE - 25 Dec 2025
The decline in ovarian endocrine function represents a pivotal event in female aging, initiating systemic biological deterioration well before the end of reproductive capacity. We propose that Hormone Replacement Therapy (HRT) may constitute an early stage geroprotective intervention with mechanistic relevance across the 12 hallmarks of aging. Despite extensive clinical use, HRT remains underut...
Emotional Management In Chronic Disease.
Sanjay Kalra; Hitesh Punyani; Madhur Verma; Nitin Kapoor
JPMA. THE JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION - 01 Dec 2025
Persons living with chronic disease present with a wide array of emotions. These range from affable and accepting, action- oriented attitude, to anxious, afraid or apathic, adynamic acceptance of disease. Yet others may be argumentative and angry, or openly aggressive and antisocial. Increasingly, primary care practitioners also encounter 'pseudo academic' or hyperaware' patients, who base thei...
Impactful behavioural therapy (IBT) in obesity care.
Sanjay Kalra; Madhur Verma; Nitin Kapoor
JPMA. THE JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION - 01 Dec 2025
Intensive behavioural therapy is said to be the first line treatment of obesity. The choice of the adjective 'intensive', however, is open to debate. The term 'impactful behavioural therapy' seems more appropriate for the management of persons living with obesity. This refers to a sustained supportive psychosocial intervention, embedded in routine care, designed to modify existing behaviours, a...
High-salt diet induces immune-independent re-differentiation, metabolic shut down and cell cycle arrest of melanoma.
Clivia Lisowski; Natascha E Stumpf; Katarzyna Jobin; Daniela Klaus; Melanie Eichler; Ann-Kathrin Baumgart; Olena Babyak; Mirjam Meißner; Agnes Schröder; Patrick Neubert; Vanessa Schmitt; Marcel Michla; Süleyman Bozkurt; Jelena Zurkovic; Daniel Hinze; Jana Liebing; Matthias Eckhardt; Christoph Heuser; Lea Seep; Annkristin Heine; Janine Becker-Gotot; Christoph Thiele; Christian Münch; Thomas Becker; Jonathan Jantsch; Christoph Wilhelm; Michael Hölzel; Christian Kurts
CELL DEATH & DISEASE - 20 Dec 2025
High salt diet (HSD) is known to reduce cancer growth in some tumor models, which has been attributed to tissue accumulation of sodium that enhances local anti-tumor immunity. Here, we show that a HSD inhibits melanoma growth independent of sodium accumulation and immune cells in skin and lung. Melanoma cells from mice on a HSD upregulated the metabolic inhibitor Tuberous sclerosis complex 2 (T...
Immune and metabolic signatures characterise constipation-driven endophenotypes in Parkinson's disease.
Abbey Figliomeni; Samantha Winter; Madison Abonnel; Jade Kenna; Samantha Lodge; Luke Whiley; Andres Bernal; Jerome D Coudert; Jonathan Noonan; Belinda Kaskow; Ryan Anderton
NPJ PARKINSON'S DISEASE - 20 Dec 2025
Parkinson's disease (PD) is a progressive neurodegenerative disorder defined by motor impairments. However, people with PD (PwPD) experience a defined spectrum of non-motor symptoms, with gastrointestinal dysfunction the most common and earliest-presenting. Evidence suggests that PD pathology may originate in the gut, where microbial dysbiosis and immune dysregulation contribute to neuroinflamm...
PM2.5 promotes non-small cell lung cancer tumorigenesis by miR-21-5p targeting <i>PDE4DIP</i> accumulated.
Yan-Jun Lin; Yuan-Hao Wu; Jingqing Ma; Lu Fang; Bo Liu; Shu Meng
TRANSLATIONAL CANCER RESEARCH - 30 Nov 2025
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Fine particulate matter (PM2.5) is associated with increased risk of lung cancer. microRNAs (miRNAs) play an important role in a variety of cancers, including NSCLC. In NSCLC, existing literature has revealed upregulation of miR-21-5p. Nonetheless, the molecular mechanism of miR-21-5p in NSCLC develop...
Diabetes in adolescents without obesity in India: An underrecognized phenotype.
Rashi Agrawal; Akhila Bhandarkar; Nitin Kapoor
WORLD JOURNAL OF CLINICAL PEDIATRICS - 09 Dec 2025
Adolescent type 2 diabetes mellitus (T2DM) is on the rise in India and is commonly attributed to co-existence of overweight and obesity in adolescents. In this line, a study by Maheshwari <i>et al</i> titled 'Prevalence of obesity, determinants, and its association with hyperglycaemia among community dwelling older adolescents in India' concluded that overweight, obesity, socioeconomic factors ...
Soluble RAGE further stratifies risk of coronary artery and end-stage kidney disease in high-risk individuals with type 1 diabetes and treatment-resistant hypertension.
Krishna Adeshara; Raija Lithovius; Stefan Mutter; Valma Harjutsalo; Markku Lehto; Per-Henrik Groop; Niina Sandholm;
CARDIOVASCULAR DIABETOLOGY - 12 Dec 2025
Soluble receptor for advanced glycation end-products (sRAGE) modulates RAGE-mediated inflammation and oxidative stress. We investigated if sRAGE stratifies cardiovascular and kidney disease risk in individuals with type 1 diabetes and baseline treatment-resistant hypertension (TRH). This study included 1262 adults with type 1 diabetes from the FinnDiane study who were on antihypertensive therap...
Midlife and the menopause transition in type 2 diabetes mellitus prevention.
Maxine E Whelan; Sathish Thirunavukkarasu; Karen Pearce; David W Dunstan; Simon J Griffin; Susan R Davis; Annice Mukherjee; Robyn J Tapp
NATURE REVIEWS. ENDOCRINOLOGY - 01 Dec 2025
Sleep and physical activity trade-offs and dementia risk: a prospective cohort study in UK Biobank participants.
Stephanie Yiallourou; Lachlan Cribb; Beaudan Campbell-Brown; Christian Brakenridge; Andree-Ann Baril; Matthew P Pase
BMC MEDICINE - 03 Dec 2025
Engaging in regular physical activity and obtaining recommended amounts of sleep are touted as strategies to promote healthy brain aging. However, as each day is only 24 h long, changing time spent in one activity must come at the expense or gain of another, making it necessary to understand how the whole 24-h activity composition is associated with dementia risk. We investigated the effect of ...
Show more...